Cardiology

New drugs might give heart patients an edge

(HealthDay)—In the search for better medicines to safely help heart patients, clinical trials testing three new drugs appear to offer some promise.

Cardiology

New drug inclacumab reduces heart damage

A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial ...

Cardiology

Lack of aspirin before angioplasty linked with higher mortality

Despite recommendations from leading medical groups, a surprising number of patients are not given aspirin before artery-clearing coronary angioplasty and stenting, and those patients have a significantly higher in-hospital ...

Diabetes

In STEMI, diabetes linked to worse long-term outcomes

(HealthDay)—In patients undergoing primary angioplasty for ST-segment elevation myocardial infarction (STEMI), diabetes is associated with worse long-term outcomes, including mortality, reinfarction, stent thrombosis, and ...

Cardiology

Researchers advocate better access to angioplasty treatment

New research from the United Kingdom has found that primary angioplasty does increase the survival rate of heart attack patients. The Imperial College London researchers said recent studies examining the role of specialist ...

page 7 from 18